Cargando…
Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1–IL‐8 signaling‐mediated epithelial–mesenchymal transition in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is a major subtype of non–small‐cell lung cancer, which is the leading cause of cancer death worldwide. The histone H3K36 methyltransferase SETD2 has been reported to be frequently mutated or deleted in types of human cancer. However, the functions of SETD2 in tumor growth...
Autores principales: | Yang, Xin, Chen, Rui, Chen, Yan, Zhou, You, Wu, Chen, Li, Qing, Wu, Jun, Hu, Wen‐wei, Zhao, Wei‐qing, Wei, Wei, Shi, Jun‐tao, Ji, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990294/ https://www.ncbi.nlm.nih.gov/pubmed/35152527 http://dx.doi.org/10.1111/cas.15299 |
Ejemplares similares
-
Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer
por: Wu, Jugang, et al.
Publicado: (2021) -
FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition
por: Yu, Jie, et al.
Publicado: (2020) -
Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
por: Chen, Rui, et al.
Publicado: (2020) -
Inhibition of histone methyltransferase SETD8 represses DNA virus replication
por: Chen, Lin, et al.
Publicado: (2022) -
The dynamic conformational landscape of the protein methyltransferase SETD8
por: Chen, Shi, et al.
Publicado: (2019)